Company intelligence / Profile preview
Hunter Biodiscovery
Hangzhou, Zhejiang, Chinahunter.bio ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Hunter Biodiscovery uses microfluidics technology to rapidly screen drug combinations on live cells to identify synergistic drug pairs for further development.
- Therapeutic areas
- OncologyOther
- Modalities
- Drug combinationsSmall molecules
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Hunter Biodiscovery.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hunter Biodiscovery.